31
KIT
As a driver, I can
now work safely
again thanks
to the mask ~
Michelangelo
Biasiucci
The sleep mask treatment can
be worn during normal hours of
sleep. Michelangelo Biasiucci, 64,
from London, is someone whose
life has been transformed by using
the sleep mask. He says, "After
being referred to the hospital by my
GP, I was diagnosed with diabetic
retinopathy. Part of my treatment
for this was to have injections in my
eyes, and looking back, I don't know
how I tolerated them! I was relieved
that not so long after, my consultant
prescribed the mask. I would say that
the mask has given me my life back.
As a driver, I can now work safely
again thanks to the mask."
The mask maintains or improves
the person's vision and the
physiological effects of diabetes
on their eyes by delivering a
precise level of light at a particular
wavelength during a person's normal
hours of sleep in a home-based
setting. Noctura 400 administers
low-level light to prevent the eyes'
increased demand of oxygen at
night and reduces the damaging
effects of diabetic retinopathy on
their eyesight.
Trust
Commenting on the treatment's
benefits Mr Ulrich Meyer-Bothling,
Consultant Ophthalmic Surgeon
at Ashford and St Peter's Hospitals
NHS Foundation Trust, said of the
study, "The Trust's decision to offer
the sleep mask as part of its diabetic
retinopathy pathway is great news
for patients and the NHS alike.
"For patients, it represents a
pain-free treatment option for their
condition. It is non-invasive, and
they are, in effect, treated while they
sleep. It also doesn't require patients
to attend the hospital as frequently,
giving them more of their time back.
It represents a gentler approach to
treating or even preventing diabetic
retinopathy and diabetic macular
oedema. I'm proud that most of
the patients I have treated with
the mask have shown stabilisation
and improvement in their diabetic
eye disease."
Chief Executive of PolyPhotonix,
Richard Kirk, adds, "For the NHS,
treating diabetic retinopathy
patients with the Noctura400 sleep
mask represents a cost-effective
alternative to existing treatments.
At a time when our healthcare
budgets are already stretched,
adding the sleep mask to existing
care pathways makes sound financial
sense in helping healthcare services
recover from the pandemic and
freeing up hospital appointments
for those in greater need of
emergency care. Most importantly,
it prevents problems before they
arise and enables doctors to improve
patient care."
PolyPhotonixis a bio-photonic
research and development company
that designs, develops, and
manufactures non-invasive photonicbased
medical devices focused on
light therapy treatments for macular
eye disease. PolyPhotonix' Noctura
400 Sleep Mask is an innovative, noninvasive,
and monitored home care
treatment developed to prevent and
treat diabetic retinopathy.
www.polyphotonix.com
1. Meyer-Bothling U, MeyerBothling O,
PinneyM. A RealWorld
Single-Centre Study of
Patients with Diabetic Macular
Oedema Who Wore a Home-Use
Sleep Mask (Noctura 400) for One
Year.Journal of Ophthalmology.
2021. --> Meyer-Bothling U,
Meyer-Bothling O, Pinney M. A
Real-World Single-Centre Study
of Patients with Diabetic Macular
Oedema Who Wore a Home-Use
Sleep Mask (Noctura 400) for One
Year. Journal of Ophthalmology.
2021;2021:6612126
2. PolyPhotonix Data on File. 2021.
3. Hristova E, Koseva D, Zlatarova Z,
Dokova K. Diabetic Retinopathy
Screening and Registration
in Europe-Narrative Review.
Healthcare (Basel). 2021;9(6): 745.
4. NHS England. NHS Prevention
Programme cuts chances
of Type 2 diabetes for
thousands. 2022.